HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of EUR 104.45 billion. The enterprise value is 148.27 billion.
| Market Cap | 104.45B |
| Enterprise Value | 148.27B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Dec 15, 2025 |
Share Statistics
| Current Share Class | 223.55M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -8.52% |
| Shares Change (QoQ) | -2.32% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 62.83% |
| Float | 151.14M |
Valuation Ratios
The trailing PE ratio is 18.08 and the forward PE ratio is 17.85.
| PE Ratio | 18.08 |
| Forward PE | 17.85 |
| PS Ratio | 1.62 |
| PB Ratio | -44.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.94 |
| P/OCF Ratio | 9.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.36, with an EV/FCF ratio of 22.63.
| EV / Earnings | 25.66 |
| EV / Sales | 2.27 |
| EV / EBITDA | 10.36 |
| EV / EBIT | 14.28 |
| EV / FCF | 22.63 |
Financial Position
The company has a current ratio of 0.97
| Current Ratio | 0.97 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.95 |
| Debt / FCF | 6.33 |
| Interest Coverage | 5.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.44% |
| Return on Invested Capital (ROIC) | 21.55% |
| Return on Capital Employed (ROCE) | 26.97% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 234,140 |
| Profits Per Employee | 21,011 |
| Employee Count | 320,000 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 26.09 |
Taxes
In the past 12 months, HCA Healthcare has paid 1.75 billion in taxes.
| Income Tax | 1.75B |
| Effective Tax Rate | 20.85% |
Stock Price Statistics
The stock price has increased by +55.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +55.45% |
| 50-Day Moving Average | 417.89 |
| 200-Day Moving Average | 370.30 |
| Relative Strength Index (RSI) | 61.02 |
| Average Volume (20 Days) | 5 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.31 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of EUR 64.39 billion and earned 5.78 billion in profits. Earnings per share was 24.13.
| Revenue | 64.39B |
| Gross Profit | 26.72B |
| Operating Income | 10.19B |
| Pretax Income | 8.37B |
| Net Income | 5.78B |
| EBITDA | 13.19B |
| EBIT | 10.19B |
| Earnings Per Share (EPS) | 24.13 |
Balance Sheet
The company has 973.49 million in cash and 41.48 billion in debt, giving a net cash position of -40.50 billion.
| Cash & Cash Equivalents | 973.49M |
| Total Debt | 41.48B |
| Net Cash | -40.50B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2.36B |
| Book Value Per Share | -22.85 |
| Working Capital | -482.91M |
Cash Flow
In the last 12 months, operating cash flow was 10.76 billion and capital expenditures -4.21 billion, giving a free cash flow of 6.55 billion.
| Operating Cash Flow | 10.76B |
| Capital Expenditures | -4.21B |
| Free Cash Flow | 6.55B |
| FCF Per Share | n/a |
Margins
Gross margin is 41.50%, with operating and profit margins of 15.83% and 8.97%.
| Gross Margin | 41.50% |
| Operating Margin | 15.83% |
| Pretax Margin | 13.01% |
| Profit Margin | 8.97% |
| EBITDA Margin | 20.49% |
| EBIT Margin | 15.83% |
| FCF Margin | 10.17% |
Dividends & Yields
This stock pays an annual dividend of 2.51, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 2.51 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | 2.85% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 10.01% |
| Buyback Yield | 8.52% |
| Shareholder Yield | 9.08% |
| Earnings Yield | 5.53% |
| FCF Yield | 6.27% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.62 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 6 |